Intellia Therapeutics (NTLA) PT Lowered to $107 at Chardan Capital Markets

June 13, 2023 7:34 AM EDT Send to a Friend

Chardan Capital Markets analyst Geulah ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Intellia Therapeutics (NTLA) PT Lowered to $107 at Chardan Capital Markets

Member Login

Free News Feed